Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres …

KT Brown, RK Do, M Gonen, AM Covey… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Transarterial chemoembolization is accepted therapy for hepatocellular carcinoma
(HCC). No randomized trial has demonstrated superiority of chemoembolization compared …
被引用次数：390 相关文章

Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With …

KT Brown, RK Do, M Gonen, AM Covey… - Journal of Clinical …, 2016 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Transarterial chemoembolization is
accepted therapy for hepatocellular carcinoma (HCC). No randomized trial has …

Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With …

KT Brown, RK Do, M Gonen, AM Covey… - Journal of Clinical …, 2016 - europepmc.org
Purpose Transarterial chemoembolization is accepted therapy for hepatocellular carcinoma
(HCC). No randomized trial has demonstrated superiority of chemoembolization compared …

Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With …

KT Brown, RK Do, M Gonen… - Journal of clinical …, 2016 - pubmed.ncbi.nlm.nih.gov
Purpose Transarterial chemoembolization is accepted therapy for hepatocellular carcinoma
(HCC). No randomized trial has demonstrated superiority of chemoembolization compared …
[PDF] researchgate.net

[PDF][PDF] Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With …

KT Brown, RK Do, M Gonen, AM Covey… - J Clin …, 2016 - researchgate.net
Purpose Transarterial chemoembolization is accepted therapy for hepatocellular carcinoma
(HCC). No randomized trial has demonstrated superiority of chemoembolization compared …
[HTML] nih.gov

[HTML][HTML] Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With …

KT Brown, RK Do, M Gonen, AM Covey… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
Purpose Transarterial chemoembolization is accepted therapy for hepatocellular carcinoma
(HCC). No randomized trial has demonstrated superiority of chemoembolization compared …

Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With …

KT Brown, RK Do, M Gonen, AM Covey… - Journal of Clinical …, 2016 - europepmc.org
Purpose Transarterial chemoembolization is accepted therapy for hepatocellular carcinoma
(HCC). No randomized trial has demonstrated superiority of chemoembolization compared …